Morepen Laboratories Ltd.
MOREPENLAB Share PricePharmaceuticals & Drugs
₹51.22
2.1 (4.3%)
As on September 9, 2025
Exchange Scrips: BSE500288NSEMOREPENLABISININE083A01026
Market Cap ₹ 2,808 Cr
P/E Ratio 23.78
Dividend Yield 0.2 %
Performance
Market performance
Open50
High51.95
Volumes97,31,534
Prev51.22
Low50
As on2025-09-09
Historical performance
1 Year High100.9
3 Year High100.9
5 Year High100.9
1 Year Low42
3 Year Low23.6
5 Year Low22.35
Fundamentals
Company Valuation
Market Cap (₹Cr)
2,808
Face Value (₹)
2
P/E Ratio
23.78
Dividend Yield
0.2 %
Investment Returns
1 Year
-45.5%
3 Years
48.9%
5 Years
113%
10 Years
318.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 49.82 | Bullish |
| 10-DMA | 48.65 | Bullish |
| 20-DMA | 48.34 | Bullish |
| 50-DMA | 55.56 | Bearish |
| 100-DMA | 58.82 | Bearish |
| 200-DMA | 61.31 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 35 | 35 | 35 | 35 | 35 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 35 | 35 | 35 | 35 | 35 |
| Public Investors | 461145 | 468825 | 448326 | 430894 | 348731 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 23.78.
- 3Y Stock Price CAGR of the stock is 14.4.
- The stock has a beta of 1.9.
- In the last financial year, the company had an EBITDA of ₹1924 Million.
- The company generated revenue of ₹18116 Million in the previous financial year.
Morepen Laboratories Ltd.
51.222.1 (4.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 532487.8
No. of Shares: 10396 (Approx)
Performance:-46.8%
P/L: ₹-467512.2
Top Gainers
| Symbol | Change% |
|---|---|
| ITDC | 653.6(20%) |
| LASA | 12.74(20%) |
| PRECAM | 254.93(16%) |
| JTEKTINDIA | 181.94(15%) |
| QUICKHEAL | 335.1(14%) |
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent